Divi's Laboratories Ltd.

Financial

	Divi's Lab	Aurobindo Pharma	Laurus Labs
Operational Metrics
Pharmaceutical Sector
R&D as a % of Total Sales	0.91 %	5.2 %	4.8 %
Financials
5 yr Average ROE	19.83 %	15.24 %	20.05 %
5yr average Equity Multiplier	1.24	1.59	2.06
5yr Average Asset Turnover Ratio	0.57	0.72	0.74
5yr Avg Net Profit Margin	27.57 %	13.0 %	12.47 %
Price to Book	8.94	2.38	5.74
P/E	75.82	22.4	149.57
5yr Avg Cash Conversion Cycle	141.33 Days	-29.67 Days	109.81 Days
Inventory Days	115.55 Days	60.22 Days	110.32 Days
Days Receivable	98.41 Days	30.42 Days	117.42 Days
Days Payable	95.88 Days	111.73 Days	143.67 Days
5yr Average Interest Coverage Ratio	995.2	43.11	9.19
5yr Avg ROCE	24.63 %	18.43 %	24.17 %
5yr Avg Operating Profit Margin	39.96 %	20.43 %	24.88 %
5 yr average Debt to Equity	0.0	0.27	0.56
5yr CAGR Net Profit	6.15 %	-4.01 %	-9.19 %
5yr Average Return on Assets	15.99 %	9.53 %	9.61 %
Shareholdings
Promoter Holding	51.92 %	51.83 %	27.19 %
Share Pledged by Promoters	0.0	20.86 %	0.0
Change in Promoter Holding (3 Yrs)	-0.03 %	-0.11 %	-0.26 %
Change in Mutual Fund Holding (3 Yrs)	1.69 %	8.99 %	4.63 %

Business

	Divi's Lab	Aurobindo Pharma	Laurus Labs
Product Wise Break-Up	Product Wise Break-Up Custom Synthesis 51.0 API 49.0 Nutraceuticals 0 API 0 Formulations 0 Bio 0 Generics FDF 0 Ingredients 0 Synthesis 0 Generic API 0	Product Wise Break-Up Active Pharmaceutical Ingredient (API) 13.44 Bio 0 Nutraceuticals 0 Custom Synthesis 0 Generics FDF 0 Generic API 0 Ingredients 0 Formulations 85.88 Synthesis 0 Others 0.68	Product Wise Break-Up API 0 Bio 2.0 Nutraceuticals 0 Custom Synthesis 0 Formulations 30.0 Active Pharmaceutical Ingredient (API) 52.0 Ingredients 0 Formulations 0 Synthesis 16.0
Location Wise Break-Up	Location Wise Break-Up Europe 40.13 USA 28.87 Asia Pacific 13.63 India 11.46 Rest of the World 4.58 North America 0 Others 1.33	Location Wise Break-Up North America 0 Rest of the World 19.5 USA 47.3 Asia Pacific 0 Europe 24.2 India 9.0	Location Wise Break-Up North America 17.0 Rest of the World 56.0 USA 0 Asia Pacific 0 Europe 27.0 India 0
Brand Wise Break-Up	Brand Wise Break-Up Naproxen and Dextromethorphan HBr 26.0 Others 74.0	-	-
Asset Break-Up	Asset Break-Up India 99.92 USA 0.05 Europe 0 Others 0.03	Asset Break-Up USA 24.19 Europe 8.77 India 60.08 Others 6.96	-